Availability of 2025 Half-Year Financial Report

Core Insights - EUROAPI released its 2025 condensed Half-Year Consolidated Financial Statements for the six months ending June 30, 2025, available on its website [1][2] - The company focuses on reinventing active ingredient solutions to meet global customer and patient needs, with a portfolio of approximately 200 products [3] - EUROAPI operates five manufacturing sites in Europe and supplies customers in over 80 countries, emphasizing high-quality API manufacturing [4] Financial Overview - The report includes the 2025 half-year management report and the consolidated financial statements as of June 30, 2025 [2] - The Statutory Auditors' review report on the half-yearly financial information is also part of the documentation [2] Company Profile - EUROAPI is a leading player in active pharmaceutical ingredients, developing innovative molecules through its Contract Development and Manufacturing Organization (CDMO) activities [3] - The company employs approximately 3,270 individuals dedicated to enabling access to essential therapies [4] - EUROAPI is listed on Euronext Paris under the ticker EAPI [4]